New York, NY, February 21, 2008 – Researchers in the U.S. have successfully created primitive cells derived from human embryonic stem cells that reversed chemically induced diabetes in mice, the scientific journal Nature Biotechnology reported last night. The finding represents exciting progress to better understand and develop new therapies for type 1 diabetes. JDRF, the world’s largest charitable funder of type 1 diabetes research, partially funded the development of the human embryonic stem cell lines used in this study.
Hi , I’m looking for some good news, this is good news, every step is a good one if it brings us closer to finding a cure.